Heme Complete Red Emphasis Study Guide

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/164

encourage image

There's no tags or description

Looks like no tags are added yet.

165 Terms

1
New cards

What abnormal chromosome defines CML?

Philadelphia chromosome, t(9;22).

2
New cards

Which two chromosomes participate in the Philadelphia translocation?

Chromosomes 9 and 22.

3
New cards

Which genes fuse in CML?

BCR on chromosome 22 and ABL1 on chromosome 9, forming BCR-ABL1.

4
New cards

What protein activity drives CML?

Constitutively active BCR-ABL1 tyrosine kinase.

5
New cards

How common is the Philadelphia chromosome in CML?

about 95%

6
New cards

What happens to the LAP score in CML?

Decreased

7
New cards

What happens to the LAP score in a leukemoid reaction?

increased

8
New cards

What is the normal LAP score range according to the professor?

15-170; no calculations required

9
New cards

What abnormality in the differential supports CML?

Basophilia, often with eosinophilia and a myelocyte bulge.

10
New cards

What is the classic first-line treatment for CML in the slides?

Imatinib (Gleevec), a tyrosine kinase inhibitor.

11
New cards

What is the target of imatinib?

BCR-ABL1 tyrosine kinase.

12
New cards

What phase is CML with 10-19% blasts?

Accelerated phase.

13
New cards

What peripheral basophil percentage supports accelerated CML?

20% or more

14
New cards

What blast threshold marks blast phase?

about 20% or more blasts

15
New cards

What is a typical chronic-phase CML blast percentage?

Less than 10%

16
New cards

Which treatment has curative potential in CML?

Hematopoietic stem cell transplantation

17
New cards

What mutation is associated with chronic neutrophilic leukemia?

CSF3R

18
New cards

How does chronic neutrophilic leukemia differ genetically from CML?

It lacks BCR-ABL1/Philadelphia chromosome.

19
New cards

What WBC and neutrophil pattern is listed for chronic neutrophilic leukemia?

WBC over 25,000/µL and neutrophils over 80%.

20
New cards

Which mutation strongly indicates polycythemia vera?

JAK2 V617F, or occasionally JAK2 exon 12.

21
New cards

Which amino acids change in JAK2 V617F?

Valine changes to phenylalanine at position 617

22
New cards

What is the main feature of PV?

Increased RBC mass with panmyelosis of erythroid, granulocytic, and megakaryocytic lineages.

23
New cards

What are the major criteria for PV?

Increased hemoglobin/hematocrit or RBC mass; marrow panmyelosis; JAK2 mutation.

24
New cards

What is the minor PV criterion?

Low/subnormal serum erythropoietin.

25
New cards

Which PV diagnostic combination is taught?

All three major, or first two major plus the minor criterion.

26
New cards

What hemoglobin cutoffs support PV?

Men >16.5 g/dL; women >16.0 g/dL.

27
New cards

What hematocrit cutoffs support PV?

Men >49%; women >48%.

28
New cards

What is therapeutic phlebotomy's target in PV?

Hematocrit below 45%.

29
New cards

What is a classic complication of PV?

Thrombosis; secondary bleeding may also occur

30
New cards

Which mutation genes occur in essential thrombocythemia?

JAK2, CALR, or MPL.

31
New cards

What is the major platelet cutoff for ET?

Platelets ≥450 × 10⁹/L.

32
New cards

What lineage proliferates mainly in ET?

Megakaryocytes (megakaryopoiesis).

33
New cards

What platelet morphology and marrow architecture appear in the highlighted ET diagram?

Giant/abnormal platelets, enlarged hyperlobulated megakaryocytes and megakaryocyte clustering, without significant granulocytic/erythroid expansion.

34
New cards

What are the four major ET criteria?

Platelets ≥450 × 10⁹/L; characteristic marrow megakaryocytes; exclusion of other myeloid neoplasms; JAK2/CALR/MPL mutation

35
New cards

What is the minor ET criterion?

Clonal marker or absence of evidence for reactive thrombocytosis.

36
New cards

What is the ET diagnosis rule?

All four major, or the first three major plus the minor criterion.

37
New cards

What finding argues against primary ET?

Reactive (secondary) thrombocytosis as the explanation for a high platelet count.

38
New cards

What treatment options for ET are listed?

Plateletpheresis, hydroxyurea, and low-dose aspirin

39
New cards

What causes fibrosis in primary myelofibrosis?

PDGF and other growth factors released by atypical megakaryocytes stimulate reactive marrow fibroblasts.

40
New cards

What mutations are seen in PMF?

JAK2, CALR, or MPL.

41
New cards

What peripheral smear findings support PMF?

Teardrop RBCs, immature granulocytes, and nucleated RBCs.

42
New cards

What is the fibrosis grade in prefibrotic PMF?

Grade 0-1 or no significant marrow fibrosis.

43
New cards

What is the fibrosis grade in overt PMF?

Grade 2-3 reticulin/collagen fibrosis

44
New cards

What does the red-circled major criterion of overt PMF emphasize?

Megakaryocytic proliferation and atypia accompanied by grade 2 or 3 reticulin/collagen fibrosis.

45
New cards

What is the diagnostic rule for PMF shown in its criteria tables?

All three major and at least one minor criterion.

46
New cards

What additional minor criterion appears in overt PMF?

Leukoerythroblastosis

47
New cards

What is the only curative treatment listed for PMF?

Stem cell transplantation

48
New cards

What peripheral abnormality characterizes CMML?

Persistent monocytosis

49
New cards

What genetic abnormalities appear in the CMML notes?

Deletion 7 and trisomy 8; CMML is an MDS/MPN overlap disorder.

50
New cards

What fundamentally causes peripheral cytopenias in MDS despite hypercellular marrow?

Ineffective hematopoiesis and apoptosis of dysplastic precursors.

51
New cards

Which blood lineages may be dysplastic in MDS

Erythroid, granulocytic, and megakaryocytic.

52
New cards

What anemia pattern is typical in MDS?

normocytic to macrocytic anemia

53
New cards

Which RBC abnormalitu is highlighted in red on MDS morphology slides?

oval macrocytes

54
New cards

What does a dimorphic RBC population mean in MDS?

Two distinct populations of RBC with different sizes or appearances

55
New cards

What does poikilocytosis describe?

variation in RBC shape

56
New cards

What three RBC inclusions/features are emphasized in the MDS slide?

basophilic stippling, Howell-Jolly bodies, and Pappenheimer bodies

57
New cards

What additional marrow erythroid abnormalities may appear in MDS?

multinucleation, abnormal nuclear bridgins/buds, and ringed sideroblasts

58
New cards

Which mutation is associated with ring sideroblasts in MDS?

SF3B1

59
New cards

Which classification category appears in red in the MDS notes?

The WHO classification of MDS, including SLD, MLD, isolated del(5q), excess blasts, SF3B1-mutated, NOS without dysplasia, and MDS/AML.

60
New cards

What does MDS-SLD mean?

MDS with single-lineage dysplasia.

61
New cards

What does MDS-MLD mean? MDS with multilineage dysplasia

MDS with multilineage dysplasia

62
New cards

Which MDS classification uniquely allows thrombocytosis?

MDS with isolated del(5q).

63
New cards

What is the highlighted marrow blast range for MDS-EB?

5-9%

64
New cards

What is the highlighted blast range for MDS/AML?

10-19% in marrow or peripheral blood

65
New cards

What blast percentage generally indicates AML rather than MDS?

20% or more, subject to genetic exceptions.

66
New cards

What marrow and peripheral blood blast limits are shown for isolated del(5q) MDS?

Marrow

67
New cards

What are characteristic findings of isolated del(5q) MDS?

Macrocytic anemia, possible thrombocytosis, and hypolobated megakaryocytes.

68
New cards

What medication is especially useful for MDS with del(5q)?

Lenalidomide

69
New cards

What other MDS therapies are listed?

Azacitidine, decitabine, transfusions, growth factors, and supportive care.

70
New cards

What is the only potentially curative treatment for MDS?

Hematopoietic stem cell transplantation.

71
New cards

Which five common cytogenetic changes are listed for MDS?

del(5q), −7, del(7q), +8, del(20q).

72
New cards

What three variables determine MDS prognosis in IPSS?

Blast burden, cytogenetics, and cytopenias; no reference values/calculations required for this exam.

73
New cards

What is the typical presentation of therapy-related MDS?

After chemotherapy/radiation; more aggressive with greater AML progression risk.

74
New cards

Which leukemia is most common in children age 2-5?

Acute lymphoblastic leukemia (ALL).

75
New cards

Which is the most common acute leukemia in adults?

Acute myeloid leukemia (AML).

76
New cards

How do acute versus chronic leukemia differ?

Acute has immature blasts and rapidly progresses; chronic has more mature cells and slower progression.

77
New cards

Which stains are usually positive in AML and negative in ALL?

MPO and Sudan Black B (SBB).

78
New cards

What does positive MPO or SBB generally rule against?

ALL

79
New cards

What is the testable cytochemical pattern for AML M0?

MPO positive and SBB positive

80
New cards

Which cells are positive for MPO?

Promyelocytes through segmented neutrophils and eosinophils; monocytes may be weakly positive.

81
New cards

Which cells are negative for MPO?

Lymphocytes, erythroid precursors, and basophils

82
New cards

Which cells are positive for SBB?

Mature neutrophils and eosinophils; monocytes vary.

83
New cards

Which cells are negative for SBB?

Lymphocytes

84
New cards

Which cells are positive for NASDA specific esterase?

Neutrophils and their precursors

85
New cards

Which cells are negative for NASDA?

Monocytes and lymphocytes

86
New cards

Which cells are positive for nonspecific (butyrate) esterase?

Monocytes and macrophages; some T cells show focal positivity

87
New cards

Which marker stain is positive in hairy cell leukemia?

TRAP (tartrate-resistant acid phosphatase).

88
New cards

Which cells are PAS positive according to these notes?

Erythroblasts, megakaryocytes, and sometimes lymphoblasts with coarse block positivity.

89
New cards

What are the starred FAB M0-M7 names (in order)?

M0 minimally differentiated; M1 without maturation; M2 with maturation; M3 acute promyelocytic; M4 acute myelomonocytic; M5 acute monoblastic/monocytic; M6 erythroid; M7 megakaryoblastic.

90
New cards

What is FAB M0?

AML minimally differentiated.

91
New cards

What is FAB M1?

AML without maturation

92
New cards

What is FAB M2?

AML with maturation.

93
New cards

What is FAB M3?

Acute promyelocytic leukemia (APL).

94
New cards

What is FAB M4?

Acute myelomonocytic leukemia.

95
New cards

What is FAB M5?

Acute monoblastic/monocytic leukemia.

96
New cards

What is FAB M6?

Acute erythroid leukemia (the starred chart labels pure erythroid leukemia).

97
New cards

What is FAB M7?

Acute megakaryoblastic leukemia.

98
New cards

What is the difference between FAB and WHO classification?

FAB primarily uses morphology/maturation; WHO integrates genetic alterations and clinical/pathologic findings.

99
New cards

What is the historical FAB minimum blast cutoff for AML?

30%

100
New cards

What is the usual WHO AML blast cutoff taught in these notes?

20%, with genetic exceptions.